What the FDA labels say about taking them together
Gepotidacin and succinylcholine
Gepotidacin's FDA label of February 10, 2026 names succinylcholine in its drug interactions section; the succinylcholine labels PlainMeds reads (2) do not name gepotidacin. The gepotidacin label: “Monitor patients with underlying medical conditions that may be exacerbated by acetylcholinesterase inhibition and patients receiving succinylcholine‑type neuromuscular blocking agents, systemic anticholinergic …”
Check it at the source: the gepotidacin FDA label on DailyMed (effective February 10, 2026, GlaxoSmithKline LLC); the succinylcholine FDA label on DailyMed (effective August 18, 2026, Hospira, Inc.).
What does the gepotidacin label say about succinylcholine?
Gepotidacin label, drug interactionsAs gepotidacin is an acetylcholinesterase inhibitor, there is potential for an exaggerated effect of concomitantly administered succinylcholine‑type neuromuscular blocking agents resulting in a delay in recovery of neuromuscular function.
Gepotidacin label, warnings and precautionsMonitor patients with underlying medical conditions that may be exacerbated by acetylcholinesterase inhibition and patients receiving succinylcholine‑type neuromuscular blocking agents, systemic anticholinergic medications, or non‑depolarizing neuromuscular blocking agents.
Source: FDA drug label (Blujepa), GlaxoSmithKline LLC, effective February 10, 2026 (SPL set 80b57cfe-7819-4d95-a57d-014af42f118d), via openFDA; the full label on DailyMed
What does the succinylcholine label say about gepotidacin?
Succinylcholine's label (effective August 18, 2026) and its 1 other brand-application label do not name gepotidacin in these sections. A label lists what its studies and reports found; it is not a complete list.
Source: FDA drug label (QUELICIN), Hospira, Inc., effective August 18, 2026 (SPL set fb08161e-7711-406d-e7b3-ea4515c07983), via openFDA; the full label on DailyMed
These are the labels' own sentences. PlainMeds does not grade interactions; a pharmacist or prescriber can say what they mean for one person's medicines.
Both medicines on the record
| Gepotidacin | Succinylcholine | |
|---|---|---|
| Labeled for | Urinary tract infections | n/a |
| Boxed warning | No | Yes |
| Pharmacy cost (NADAC) | $91.40 per tablet 750 mg tablet | n/a |
| Shortage now | No current entry | A presentation being discontinued |
Source: FDA NDC Directory, CMS NADAC of October 7, 2026 and the FDA Drug Shortage Database (FDA files October 8, 2026)
What next?
- Check more medicines together
- up to five at once